These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20686910)

  • 1. Metastatic collecting duct carcinoma of the kidney responded to sunitinib.
    Miyake H; Haraguchi T; Takenaka A; Fujisawa M
    Int J Clin Oncol; 2011 Apr; 16(2):153-5. PubMed ID: 20686910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic collecting duct carcinoma of the kidney treated with sunitinib.
    Tazi EM; Essadi I; Tazi MF; Ahellal Y; M'rabti H; Errihani H
    World J Surg Oncol; 2011 Jul; 9():73. PubMed ID: 21752265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blue toe syndrome and sunitinib.
    Postema PG; Regeer MV; van der Valk PR; Stroes ES; Richel DJ
    Int J Clin Oncol; 2011 Oct; 16(5):574-6. PubMed ID: 21136131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
    De Vincenzo F; Zucali PA; Ceresoli GL; Colombo P; Simonelli M; Lorenzi E; Perrino M; Gianoncelli L; De Sanctis R; Graziotti P; Santoro A
    J Clin Oncol; 2011 Jun; 29(18):e529-31. PubMed ID: 21483010
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.
    Aksu G; Ensaroglu F; Dolasik I; Temiz S; Halis H; Sener SY; Kaya A; Uygun K
    J BUON; 2010; 15(4):798-9. PubMed ID: 21229650
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
    Park CY
    Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
    Yoshinaga A; Kamata S
    Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal acute liver failure in a patient treated with sunitinib.
    Guillen SS; Meijer M; de Jongh FE
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26933184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Therapy for Renal Cell Carcinoma.
    Joshi R; Rawal S
    JNMA J Nepal Med Assoc; 2015; 53(198):83-8. PubMed ID: 26994026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma on Sunitinib.
    Ahmad M; Prasad S; Krishna MV; Lavingia V
    Indian J Cancer; 2016; 53(1):112-3. PubMed ID: 27146756
    [No Abstract]   [Full Text] [Related]  

  • 11. Sunitinib in metastatic renal cell carcinoma: Experience from single center study, efficacy and safety.
    Patel KB; Panchal HP; Karanwal AB; Parekh BB; Shah S; Prasad S
    Indian J Cancer; 2016; 53(1):118-22. PubMed ID: 27146758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
    Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
    Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sunitinib re-challenge in metastatic renal cell carcinoma treated sequentially with tyrosine kinase inhibitors and everolimus.
    Paule B; Brion N
    Anticancer Res; 2011 Oct; 31(10):3507-10. PubMed ID: 21965770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension as a predictive factor of Sunitinib activity.
    Rixe O; Billemont B; Izzedine H
    Ann Oncol; 2007 Jun; 18(6):1117. PubMed ID: 17586751
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination.
    Keizman D; Huang P; Eisenberger MA; Pili R; Kim JJ; Antonarakis ES; Hammers H; Carducci MA
    Eur J Cancer; 2011 Sep; 47(13):1955-61. PubMed ID: 21600760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases.
    Ruggeri EM; Cecere FL; Moscetti L; Doni L; Padalino D; Di Costanzo F
    Ann Oncol; 2010 Sep; 21(9):1926-1927. PubMed ID: 20729535
    [No Abstract]   [Full Text] [Related]  

  • 17. Tyrosine kinase inhibitors in treatment of fibrous histiocytoma.
    Mauri D; Panou C; Valachis A; Kamposioras K; Tsali L
    Exp Oncol; 2009 Mar; 31(1):60-1. PubMed ID: 19300420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of sunitinib in renal cell carcinoma: where are we now?
    Czarnecka AM; Szczylik C; Rini B
    Expert Rev Anticancer Ther; 2014 Sep; 14(9):983-99. PubMed ID: 25066545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis.
    Bracarda S; Iacovelli R; Boni L; Rizzo M; Derosa L; Rossi M; Galli L; Procopio G; Sisani M; Longo F; Santoni M; Morelli F; Di Lorenzo G; Altavilla A; Porta C; Camerini A; Escudier B;
    Ann Oncol; 2015 Oct; 26(10):2107-13. PubMed ID: 26216384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma.
    Brunello A; Saia G; Bedogni A; Scaglione D; Basso U
    Bone; 2009 Jan; 44(1):173-5. PubMed ID: 18849018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.